secwatch / observer
8-K filed April 29, 2024, 7:59 PM ET ticker BLND CIK 0001855747
other material confidence high sentiment positive materiality 0.85

Blend Labs secures $150M investment from Haveli; repays $145M credit line, appoints Sheth to board

Blend Labs, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian Sheth

Director
BLND · Blend Labs, Inc.
Effective
2024-04-29
Filed
April 29, 2024, 7:59 PM ET
the Board appointed Mr. Sheth to serve as a member of the Board effective as of the Closing Date.
Departed

Ann Mather

Director
BLND · Blend Labs, Inc.
Filed
April 29, 2024, 7:59 PM ET
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.
Departed

Ciara Burnham

Director
BLND · Blend Labs, Inc.
Filed
April 29, 2024, 7:59 PM ET
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.
Departed

Erin Collard

Director
BLND · Blend Labs, Inc.
Filed
April 29, 2024, 7:59 PM ET
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Sheth was appointed as Director at Blend Labs, Inc..

Action
appointed
Role
Director
Exact text from the filing
the Board appointed Mr. Sheth to serve as a member of the Board effective as of the Closing Date.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ann Mather departed as Director at Blend Labs, Inc..

Action
not standing for reelection
Role
Director
Exact text from the filing
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Ciara Burnham departed as Director at Blend Labs, Inc..

Action
not standing for reelection
Role
Director
Exact text from the filing
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Erin Collard departed as Director at Blend Labs, Inc..

Action
not standing for reelection
Role
Director
Exact text from the filing
On April 23, 2024, each of Ann Mather, Ciara Burnham and Erin Collard informed the Company that they would not stand for reelection to the Board at the Company’s Annual Meeting.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Blend Labs, Inc. entered into Investment Agreement with Haveli Brooks Aggregrator, L.P. valued at $150 million (effective 2024-04-29).

Action
entry
Agreement
equity purchase
Counterparty
Haveli Brooks Aggregrator, L.P.
Value
$150 million
Effective
2024-04-29
Exact text from the filing
On April 29, 2024 (the “Closing Date”), Blend Labs, Inc., a Delaware corporation (the “Company” or “Blend”), entered into an Investment Agreement (the “Investment Agreement”) with Haveli Brooks Aggregrator, L.P. (the “Investor” or “Haveli”) and issued 150,000 shares of the Company’s Series A Convertible Preferred Stock, par value $0.00001 per share (the “Series A Preferred Stock”), for an aggregate purchase price of $150 million, or $1,000 per share (the “Issuance”).
View on SEC.gov

290 material agreements filed in the last 30 days. Browse all material agreements →

Blend Labs, Inc. filing history →

Source: SEC EDGAR
accession 0001855747-24-000043
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.